Olle Carl Hernell

Title: Olle Carl Hernell: Innovator in Bile Salt-Stimulated Lipase Variants

Introduction

Olle Carl Hernell is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of variants of Bile Salt-Stimulated Lipase (BSSL). With a total of 2 patents, Hernell's work has implications for both medical and nutritional applications.

Latest Patents

Hernell's latest patents include "Nucleic acids encoding BSSL variants" and "Transgenic non-human mammals producing BSSL variants." The first patent discloses nucleic acids that encode variant BSSL enzymes, which maintain catalytic activity while having fewer glycosylation sites than full-length BSSL. This innovation facilitates the purification and characterization of recombinant BSSL proteins. The second patent relates to novel polypeptides that are variants of BSSL, along with DNA molecules encoding these polypeptides. It also covers processes for producing transgenic non-human mammals capable of expressing the BSSL variants, as well as the use of these variants in infant formulas and pharmaceutical compositions.

Career Highlights

Olle Carl Hernell is associated with Astra Aktiebolag, a prominent company in the pharmaceutical industry. His work at Astra has allowed him to focus on innovative solutions in enzyme technology and its applications in health and nutrition.

Collaborations

Hernell has collaborated with notable colleagues such as Lennart Gustav Lundberg and Stig Lennart Hansson. These collaborations have contributed to the advancement of research in the field of lipase variants and their applications.

Conclusion

Olle Carl Hernell's contributions to the field of biochemistry, particularly through his patents on Bile Salt-Stimulated Lipase variants, highlight his role as an innovator. His work not only advances scientific understanding but also has practical applications in medicine and nutrition.